SARS-CoV-2 Nucleocapsid Phosphoprotein Fusion Protein

<strong>SARS-CoV-2 Nucleocapsid Phosphoprotein Fusion Protein</strong>_x000D_ <strong>Catalog number:</strong> B2015481_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 25 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 52 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20¬∞C_x000D_ <strong>Keywords:</strong> 2019-nCOV nucleocapsid phosphoprotein Fusion Protein_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Malik YA. Properties of Coronavirus and SARS-CoV-2 Malays J Pathol. 2020 Apr;42(1):3-11._x000D_ 2: Salarifar A, Khalili S, Rasaee MJ. Recombinant highly antigenic truncated fusion-based protein as a diagnostic antigen for anti-SARS-CoV-2 nucleocapsid antibody ELISA Protein Expr Purif. 2023 Mar;203:106200._x000D_ 3: McGuire BE, Mela JE, Thompson VC, Cucksey LR, Stevens CE, McWhinnie RL, Winkler DFH, Pelech S, Nano FE. Escherichia coli recombinant expression of SARS-CoV-2 protein fragments Microb Cell Fact. 2022 Feb 5;21(1):21._x000D_ 4: Adly AN, Bi M, Carlson CR, Syed AM, Ciling A, Doudna JA, Cheng Y, Morgan DO. Assembly of SARS-CoV-2 ribonucleosomes by truncated N(‚àó)¬†variant of the nucleocapsid protein J Biol Chem. 2023 Dec;299(12):105362._x000D_ 5: Hong SH, Oh H, Park YW, Kwak HW, Oh EY, Park HJ, Kang KW, Kim G, Koo BS, Hwang EH, Baek SH, Park HJ, Lee YS, Bang YJ, Kim JY, Bae SH, Lee SJ, Seo KW, Kim H, Kwon T, Kim JH, Lee S, Kim E, Kim Y, Park JH, Park SI, Gon√ßalves M, Weon BM, Jeong H, Nam KT, Hwang KA, Kim J, Kim H, Lee SM, Hong JJ, Nam JH. Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates Sci Adv. 2021 May 28;7(22):eabg7156._x000D_ 6: Zhao LP, Lybrand TP, Gilbert PB, Payne TH, Pyo CW, Geraghty DE, Jerome KR. Rapidly identifying new coronavirus mutations of potential concern in the Omicron variant using an unsupervised learning strategy Sci Rep. 2022 Nov 9;12(1):19089._x000D_ 7: Zhao LP, Lybrand T, Gilbert P, Payne TH, Pyo CW, Geraghty D, Jerome K. Rapidly Identifying New Coronavirus Mutations of Potential Concern in the Omicron Variant Using an Unsupervised Learning Strategy Res Sq. 2022 Feb 25:rs.3.rs-1280819._x000D_ 8: Gabitzsch E, Safrit JT, Verma M, Rice A, Sieling P, Zakin L, Shin A, Morimoto B, Adisetiyo H, Wong R, Bezawada A, Dinkins K, Balint J, Peykov V, Garban H, Liu P, Bacon A, Bone P, Drew J, Sanford DC, Spilman P, Sender L, Rabizadeh S, Niazi K, Soon-Shiong P. Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge Front Immunol. 2021 Sep 16;12:729837._x000D_ 9: Khairkhah N, Bolhassani A, Agi E, Namvar A, Nikyar A. Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen PLoS One. 2022 Jun 9;17(6):e0268251._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/33788636">10: Das JK, Roy S. A study on non-synonymous mutational patterns in structural proteins of SARS-CoV-2 Genome. 2021 Jul;64(7):665-678. </a>_x000D_ _x000D_ <strong>Products Related to SARS-CoV-2 Nucleocapsid Phosphoprotein Fusion Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>